✦ LIBER ✦

Doxorubicin and paclitaxel improve survival compared with fluorouracil, doxorubicin and cyclophosphamide for women with metastatic breast cancer

✍ Scribed by Heinz Ludwig

Book ID: 114483810
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 222 KB
Volume: 2
Category: Article
ISSN: 1363-4054
DOI: 10.1054/ebon.2001.0154

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Adjuvant docetaxel plus doxorubicin and

Adjuvant docetaxel plus doxorubicin and cyclophosphamide increases survival compared with fluorouracil plus doxorubicin and cyclophosphamide in women with operable node-positive breast cancer

✍ Vivek Roy; Edith A. Perez 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 74 KB

Improvement in Disease-Free Survival wit

Improvement in Disease-Free Survival with Doxorubicin/Docetaxel/Cyclophosphamide (TAC) Versus 5-Fluorouracil/Doxorubicin/Cyclophosphamide (FAC) as Adjuvant Therapy for Node-Positive Breast Cancer

✍ Amy I. D'Orazio; Joyce O'Shaughnessy 📂 Article 📅 2002 🏛 CIG Media Group, LP. 🌐 English ⚖ 96 KB

Pharmacogenomic Predictor of Sensitivity

Pharmacogenomic Predictor of Sensitivity to Preoperative Chemotherapy With Paclitaxel and Fluorouracil, Doxorubicin, and Cyclophosphamide in Breast Cancer

✍ Hess, K. R.; Anderson, K.; Symmans, W. F.; Valero, V.; Ibrahim, N.; Mejia, J. A. 📂 Article 📅 2006 🏛 American Society of Clinical Oncology 🌐 English ⚖ 362 KB

383 Comparative study: Pirarubicin vs do

383 Comparative study: Pirarubicin vs doxorubicin in combination with cyclophosphamide and fluorouracil in the treatment of breast cancer

✍ Z. Budišić; H. Predrijevac; P. Podolski; M. Gošev 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 291 KB

Quality of life and toxicity in breast c

Quality of life and toxicity in breast cancer patients using adjuvant TAC (docetaxel, doxorubicin, cyclophosphamide), in comparison with FAC (doxorubicin, cyclophosphamide, 5-fluorouracil)

✍ N. Hatam; N. Ahmadloo; A. Ahmad Kia Daliri; P. Bastani; M. Askarian 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 178 KB

Pegylated Liposomal Doxorubicin and Cycl

Pegylated Liposomal Doxorubicin and Cyclophosphamide as First-Line Therapy for Patients with Metastatic or Recurrent Breast Cancer

✍ Beth Overmoyer; Paula Silverman; Larry W. Holder; Debasish Tripathy; I. Craig He 📂 Article 📅 2005 🏛 CIG Media Group, LP. 🌐 English ⚖ 493 KB